Intelligene

Intelligene Equity Growth

The Year-over-Year Equity Growth of Intelligene (7832.TWO) as of Oct 20, 2026 is -11.59 %.

Equity Growth

-11.59 %

Last updated:

Year-over-Year Equity Growth of Intelligene is 2024 -11.59 % . Year-over-Year Equity Growth of Intelligene was 2023 - . It decreases by % lower compared to the previous year.

The Intelligene Equity Growth history

The Intelligene Equity Growth history
YEAREquity GrowthYoY
-11.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligene Stock analysis

What does Intelligene do? Intelligene Inc develops innovative RNA gene therapy drugs using siRNA gene compilation technology for treating pneumonia and influenza. The company focuses on research and development of nucleic acid drugs targeting all cases of pneumonia and influenza. Intelligene Inc is a Taiwan-based company with 20 full-time employees operating in the pharmaceutical industry. The company's primary revenue comes from the development and potential commercialization of its RNA-based gene therapy drugs. Intelligene Inc is engaged in the research and development of innovative nucleic acid drugs based on siRNA technology for pneumonia and influenza treatments. The firm aims to provide novel therapeutic solutions for respiratory diseases through its proprietary technology. Intelligene Inc's products target medical professionals and healthcare institutions seeking advanced treatments for pneumonia and influenza. The company's research focuses on developing drugs that address all cases of these respiratory conditions. The firm operates within the pharmaceutical sector with a specific emphasis on RNA-based therapies for respiratory illnesses. Intelligene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligene stock

Year-over-Year Equity Growth of Intelligene is -11.59 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Intelligene since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Intelligene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Intelligene

All Key Metrics — Intelligene